BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27876551)

  • 1. Stressed and Inflamed, Can GSK3 Be Blamed?
    Jope RS; Cheng Y; Lowell JA; Worthen RJ; Sitbon YH; Beurel E
    Trends Biochem Sci; 2017 Mar; 42(3):180-192. PubMed ID: 27876551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice.
    Franklin AV; King MK; Palomo V; Martinez A; McMahon LL; Jope RS
    Biol Psychiatry; 2014 Feb; 75(3):198-206. PubMed ID: 24041505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.
    King MK; Pardo M; Cheng Y; Downey K; Jope RS; Beurel E
    Pharmacol Ther; 2014 Jan; 141(1):1-12. PubMed ID: 23916593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits.
    Beurel E; Jope RS
    Transl Psychiatry; 2014 Dec; 4(12):e488. PubMed ID: 25514751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
    Wadhwa P; Jain P; Jadhav HR
    Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
    Beurel E; Grieco SF; Jope RS
    Pharmacol Ther; 2015 Apr; 148():114-31. PubMed ID: 25435019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is glycogen synthase kinase-3 a central modulator in mood regulation?
    Li X; Jope RS
    Neuropsychopharmacology; 2010 Oct; 35(11):2143-54. PubMed ID: 20668436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen synthase kinase 3 is part of the molecular machinery regulating the adaptive response to LPS stimulation in microglial cells.
    Ajmone-Cat MA; D'Urso MC; di Blasio G; Brignone MS; De Simone R; Minghetti L
    Brain Behav Immun; 2016 Jul; 55():225-235. PubMed ID: 26593276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.
    Jope RS; Roh MS
    Curr Drug Targets; 2006 Nov; 7(11):1421-34. PubMed ID: 17100582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT; Scheuing L; Liu G; Liao HM; Linares GR; Lin D; Chuang DM
    Int J Neuropsychopharmacol; 2014 Dec; 18(6):. PubMed ID: 25548109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.
    Hofmann C; Dunger N; Schölmerich J; Falk W; Obermeier F
    Inflamm Bowel Dis; 2010 Nov; 16(11):1850-8. PubMed ID: 20848477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.
    Yuskaitis CJ; Jope RS
    Cell Signal; 2009 Feb; 21(2):264-73. PubMed ID: 19007880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting Glycogen Synthase Kinase 3 Reverses Obesity-Induced White Adipose Tissue Inflammation by Regulating Apoptosis Inhibitor of Macrophage/CD5L-Mediated Macrophage Migration.
    Wang L; Wang Y; Zhang C; Li J; Meng Y; Dou M; Noguchi CT; Di L
    Arterioscler Thromb Vasc Biol; 2018 Sep; 38(9):2103-2116. PubMed ID: 30026270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory Potential of GSK-3 Inhibitors.
    Kandar CC; Sen D; Maity A
    Curr Drug Targets; 2021; 22(13):1464-1476. PubMed ID: 33461462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.
    Jope RS; Yuskaitis CJ; Beurel E
    Neurochem Res; 2007; 32(4-5):577-95. PubMed ID: 16944320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells.
    Meares GP; Mines MA; Beurel E; Eom TY; Song L; Zmijewska AA; Jope RS
    Exp Cell Res; 2011 Jul; 317(11):1621-8. PubMed ID: 21356208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes.
    Beurel E; Jope RS
    Neuroscience; 2010 Sep; 169(3):1063-70. PubMed ID: 20553816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of STAT family members by glycogen synthase kinase-3.
    Beurel E; Jope RS
    J Biol Chem; 2008 Aug; 283(32):21934-44. PubMed ID: 18550525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances.
    Polter A; Beurel E; Yang S; Garner R; Song L; Miller CA; Sweatt JD; McMahon L; Bartolucci AA; Li X; Jope RS
    Neuropsychopharmacology; 2010 Jul; 35(8):1761-74. PubMed ID: 20357757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.
    Wang H; Brown J; Gu Z; Garcia CA; Liang R; Alard P; Beurel E; Jope RS; Greenway T; Martin M
    J Immunol; 2011 May; 186(9):5217-26. PubMed ID: 21422248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.